Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $809,834 | 209 | 99.9% |
| Travel and Lodging | $395.00 | 3 | 0.0% |
| Food and Beverage | $38.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $622,850 | 154 | $0 (2023) |
| ABBVIE INC. | $187,379 | 58 | $0 (2024) |
| GENZYME CORPORATION | $38.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $152,656 | 50 | ABBVIE INC. ($152,656) |
| 2023 | $183,562 | 50 | Allergan, Inc. ($148,839) |
| 2022 | $158,287 | 43 | Allergan, Inc. ($158,287) |
| 2021 | $171,292 | 50 | Allergan, Inc. ($171,292) |
| 2018 | $27,038 | 4 | Allergan Inc. ($27,000) |
| 2017 | $117,431 | 16 | Allergan Inc. ($117,431) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 12/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 12/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 11/14/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 11/14/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 10/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,441.02 | General |
| 10/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,189.74 | General |
| 10/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 10/16/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 09/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $4,379.48 | General |
| 09/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 09/29/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 09/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 08/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,189.74 | General |
| 08/31/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,189.74 | General |
| 08/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 08/18/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 08/06/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 07/30/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,876.92 | General |
| 07/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,441.02 | General |
| 07/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 07/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 07/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 07/21/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $2,502.56 | General |
| 07/12/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $4,066.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 84 | 149 | $14,300 | $9,403 |
| 2022 | 4 | 344 | 587 | $57,392 | $21,721 |
| 2021 | 4 | 554 | 1,023 | $101,547 | $34,967 |
| 2020 | 4 | 478 | 912 | $94,685 | $28,342 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 82 | $8,250 | $5,865 | 71.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $4,050 | $2,383 | 58.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 26 | 40 | $2,000 | $1,155 | 57.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 245 | 445 | $40,600 | $13,103 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 66 | $6,650 | $4,775 | 71.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 27 | 27 | $4,050 | $2,380 | 58.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 38 | 49 | $6,093 | $1,463 | 24.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 414 | 856 | $81,675 | $26,954 | 33.0% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 87 | 102 | $12,713 | $3,064 | 24.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 30 | 30 | $4,200 | $2,623 | 62.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 35 | $2,960 | $2,326 | 78.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 355 | 738 | $75,455 | $20,894 | 27.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 62 | $5,020 | $3,757 | 74.8% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 80 | 98 | $12,250 | $2,526 | 20.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $1,960 | $1,165 | 59.4% |
About Dr. Bette Lazzaro, MD
Dr. Bette Lazzaro, MD is a Procedural Dermatology healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942334040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bette Lazzaro, MD has received a total of $810,267 in payments from pharmaceutical and medical device companies, with $152,656 received in 2024. These payments were reported across 213 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($809,834).
As a Medicare-enrolled provider, Lazzaro has provided services to 1,460 Medicare beneficiaries, totaling 2,671 services with total Medicare billing of $94,434. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Procedural Dermatology
- Location Dover, DE
- Active Since 03/14/2007
- Last Updated 05/23/2025
- Taxonomy Code 207NS0135X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942334040
Products in Payments
- ALLODERM (Device) $144,431
- NO PRODUCT DISCUSSED (Drug) $38.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.